Multinational prevalence and burden of paediatric disorders of gut–brain interaction: results of the Rome Foundation paediatric global study - Summary - MDSpire
To determine the multinational prevalence of pediatric DGBI according to the revised Rome V criteria and evaluate DGBI-related burden among children and their caregivers.
Approach:
Study Design: An online survey administered the Rome V pediatric diagnostic questionnaire to caregivers of children aged 0–17 years across four major world regions: China, Italy, Mexico, and the USA.
Survey Structure: The survey included 142 items evaluating gastrointestinal symptoms and generated 29 pediatric DGBI diagnoses, organized into Upper DGBI and Lower and Biliary DGBI.
Data Collection: Data were collected from 12 December 2024 to 1 February 2025, with quality assurance measures to exclude poor-quality responses.
Key Findings:
Pediatric DGBI affect almost one-third of children in a multinational sample.
Prevalence varies considerably according to disorder and country.
These conditions impose a substantial burden on both children and caregivers.
Interpretation:
The study provides standardized worldwide prevalence estimates for pediatric DGBI, which may enhance recognition and prompt efforts to lessen their burden.
Limitations:
The study may not fully capture the prevalence and impact of DGBI due to potential biases in caregiver reporting.
Exclusion of children with inflammatory bowel disease (IBD) or celiac disease may limit the generalizability of findings.
Conclusion:
The authors concluded that the high prevalence of pediatric DGBI underscores the necessity for healthcare providers to recognize these disorders and their impact on children's quality of life. They advocate for improved diagnostic protocols and treatment options to alleviate the burden on affected children and their families. Furthermore, the study emphasizes the importance of raising awareness among healthcare professionals and the public to foster better management and support for these conditions.
by Samuel Nurko, Tiffany Taft, Olafur S Palsson, Marc Benninga, Carlo DiLorenzo, Rachel Rosen, Miguel Saps, Johann P Hreinsson, Xiucai Fang, Mizu Jiang, Caterina Strisciuglio, Erick Toro-Monjaraz, Ami D Sperber
Earnest pursuit of a second opinion after a cancer diagnosis is a great “patient-savvy” strategy for optimizing your treatment, recovery and survivorship options